BIOMAT Database Logo BIOMAT Database Logo

Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects. 1993

R C Veith, and N Lewis, and J I Langohr, and M M Murburg, and E A Ashleigh, and S Castillo, and E R Peskind, and M Pascualy, and G Bissette, and C B Nemeroff
Geriatric Research, Education, and Clinical Center (GRECC), Department of Veterans Affairs Medical Center (DVAMC), Seattle, WA 98108.

To assess the effect of desipramine (DMI) on corticotropin-releasing-factor (CRF) activity in the central nervous system, we measured cerebrospinal fluid (CSF) concentrations of CRF in healthy volunteers following short-term administration of DMI or placebo. DMI administration for 2 days was associated with a significant dose-related reduction in CRF concentrations. There was a nonsignificant 6% reduction in CRF concentrations among the 10 subjects who received 50 mg DMI (delta CRF: -3 +/- 2 pg/ml) and a significant 14% fall in the CRF concentrations of the eight subjects who received 100 mg DMI (delta CRF: -8 +/- 3 pg/ml). The mean CSF concentration of CRF was unchanged in the six subjects randomized to placebo (delta CRF: 1 +/- 5 pg/ml). DMI administration had no effect on CSF norepinephrine concentrations (n = 24) or on plasma cortisol (n = 25). We conclude that short-term administration of DMI in healthy volunteers is associated with a dose-related reduction in CSF concentrations of CRF.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D008297 Male Males
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003346 Corticotropin-Releasing Hormone A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS. ACTH-Releasing Hormone,CRF-41,Corticotropin-Releasing Factor,Corticotropin-Releasing Hormone-41,ACTH-Releasing Factor,CRF (ACTH),Corticoliberin,Corticotropin-Releasing Factor-41,ACTH Releasing Factor,ACTH Releasing Hormone,Corticotropin Releasing Factor,Corticotropin Releasing Factor 41,Corticotropin Releasing Hormone,Corticotropin Releasing Hormone 41
D003891 Desipramine A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. Desmethylimipramine,Apo-Desipramine,Demethylimipramine,Desipramine Hydrochloride,Norpramin,Novo-Desipramine,Nu-Desipramine,PMS-Desipramine,Pertofran,Pertofrane,Pertrofran,Petylyl,Ratio-Desipramine,Apo Desipramine,Hydrochloride, Desipramine,Novo Desipramine,Nu Desipramine,PMS Desipramine,Ratio Desipramine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

R C Veith, and N Lewis, and J I Langohr, and M M Murburg, and E A Ashleigh, and S Castillo, and E R Peskind, and M Pascualy, and G Bissette, and C B Nemeroff
Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects.
April 1996, Biological psychiatry,
R C Veith, and N Lewis, and J I Langohr, and M M Murburg, and E A Ashleigh, and S Castillo, and E R Peskind, and M Pascualy, and G Bissette, and C B Nemeroff
Presence of immunoreactive corticotropin-releasing factor in human cerebrospinal fluid.
July 1983, The Journal of clinical endocrinology and metabolism,
R C Veith, and N Lewis, and J I Langohr, and M M Murburg, and E A Ashleigh, and S Castillo, and E R Peskind, and M Pascualy, and G Bissette, and C B Nemeroff
Cerebrospinal fluid concentrations of neurotensin and corticotropin-releasing factor in pediatric patients.
January 1989, Biology of the neonate,
R C Veith, and N Lewis, and J I Langohr, and M M Murburg, and E A Ashleigh, and S Castillo, and E R Peskind, and M Pascualy, and G Bissette, and C B Nemeroff
Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults.
October 2004, Biological psychiatry,
R C Veith, and N Lewis, and J I Langohr, and M M Murburg, and E A Ashleigh, and S Castillo, and E R Peskind, and M Pascualy, and G Bissette, and C B Nemeroff
Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.
August 1997, Biological psychiatry,
R C Veith, and N Lewis, and J I Langohr, and M M Murburg, and E A Ashleigh, and S Castillo, and E R Peskind, and M Pascualy, and G Bissette, and C B Nemeroff
Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders.
December 1983, The Journal of clinical endocrinology and metabolism,
R C Veith, and N Lewis, and J I Langohr, and M M Murburg, and E A Ashleigh, and S Castillo, and E R Peskind, and M Pascualy, and G Bissette, and C B Nemeroff
Active clearance of corticotropin-releasing factor from the cerebrospinal fluid.
January 1985, Neuroendocrinology,
R C Veith, and N Lewis, and J I Langohr, and M M Murburg, and E A Ashleigh, and S Castillo, and E R Peskind, and M Pascualy, and G Bissette, and C B Nemeroff
[Corticotropin-releasing factor concentrations in cerebrospinal fluid and its diurnal rhythm in patients with Cushing's disease].
August 1984, Nihon Naibunpi Gakkai zasshi,
R C Veith, and N Lewis, and J I Langohr, and M M Murburg, and E A Ashleigh, and S Castillo, and E R Peskind, and M Pascualy, and G Bissette, and C B Nemeroff
Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans.
March 1996, Annals of the New York Academy of Sciences,
R C Veith, and N Lewis, and J I Langohr, and M M Murburg, and E A Ashleigh, and S Castillo, and E R Peskind, and M Pascualy, and G Bissette, and C B Nemeroff
Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.
June 1992, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!